MOG and demyelinating disease: Our data suggest that demyelinating disorders may occur during/after SARS-CoV-2 infection, in accordance with the few isolated cases with myelitis or optic neuritis previously described [10, 11], and with a non-significant increase of MOG-IgG positivity in patients with positive SARS-CoV-2 IgG [12].